Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Polypharmacy clinical trials
3 of 12 indexed Polypharmacy trials are currently recruiting.
Corpus placement: #1,429 of 28,707 conditions by registered trial count.
12 US clinical trials · 3 currently recruiting · #1,429 of 28,707 conditions by registered trial count
Polypharmacy: 12 US clinical trials tracked, 3 recruiting.
Polypharmacy is the subject of 12 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. The most active sponsor is Kaiser Permanente, running 2 of these trials.
Enrollment posture brief
Registry condition polypharmacy
OPEN 3 | RECR 25% | LATE 0 | EARLY 0 | RANK #1429 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
Polypharmacy lists 3 open slots (25% of 12 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Polypharmacy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Polypharmacy is recruiting below its size-band peers.
3 of 12 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Polypharmacy research.
Kaiser Permanente accounts for 2 of 12 trials (16.7%). 11 distinct sponsors appear on at least one study for this condition label.
-
Typical Polypharmacy enrolment sits around 786 participants.
Median target enrolment is 786 among the 12 trials that report a genuine target (sentinel values excluded). 4 of those (33.3%) plan for fewer than 100 participants.
-
Polypharmacy research is mostly interventional.
11 interventional and 1 observational studies make up this index (91.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
12 total, page 1 of 1
Interprofessional Pharmacogenomics (IPGx) Registry and Repository
Texas A&M University
NCT06726590
The Geriatric Emergency Department Pharmacologic Harm Prevention Project
Florida Atlantic University
NCT07216846
Improving Medication Management in World Trade Center Responders
Icahn School of Medicine at Mount Sinai
NCT07022990
Pharmacist Intervention to Reduce Post-Hospitalization Utilization
Cedars-Sinai Medical Center
NCT04071951
Preemptive Pharmacogenomics Testing Among Geriatric Patients
Geisinger Clinic
NCT05091879
Reducing High-Risk Geriatric Polypharmacy Via EHR Nudges R01 Trial
Northwestern University
NCT05656560
Effectiveness of PGx Testing
Kaiser Permanente
NCT04120480
Bundled Hyperpolypharmacy Deprescribing
Kaiser Permanente
NCT05616689
A Randomized Controlled Trial to Deprescribe for Older Patients With Polypharmacy
Vanderbilt University Medical Center
NCT02979353
Tailored Medication Management Intervention
Washington University School of Medicine
NCT04717297
Standardized Patient-Centered Medication Review in Home Hospice
University of Massachusetts, Worcester
NCT03972163
Adapting the Shed-MEDS Deprescribing Intervention to Dementia Care in Assisted Living
Vanderbilt University
NCT05956665
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Polypharmacy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Polypharmacy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Polypharmacy page
12 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Polypharmacy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Kaiser Permanente sponsors the most Polypharmacy trials on record, review their full trial history before evaluating a specific study. See Kaiser Permanente's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Polypharmacy condition card totals 12 registered trials; most-linked intervention Bundled hyperpolypharmacy; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.